Figure 2

Bacterial OTUs that demonstrated differential abundances in the following comparisons (false discovery rate < 0.05). (A) Non-relapse group at week 0 vs. relapse group at week 0 of anti-TNF therapy. (B) Non-relapse group at week 24 vs. relapse group at week 24 of anti-TNF therapy. (C) Relapse group at week 0 vs. relapse group at week 24 of anti-TNF therapy. (D) Non-relapse group at week 0 vs. non-relapse group at week 24 of anti-TNF therapy.